SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-051434
Filing Date
2021-10-21
Accepted
2021-10-21 16:06:59
Documents
13
Period of Report
2021-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20211021.htm   iXBRL 8-K 40560
2 EX-99.1 mtcr-ex991_52.htm EX-99.1 27810
  Complete submission text file 0001564590-21-051434.txt   207834

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20211021.xsd EX-101.SCH 5689
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20211021_lab.xml EX-101.LAB 20069
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20211021_pre.xml EX-101.PRE 11937
6 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20211021_htm.xml XML 3678
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 211337091
SIC: 2834 Pharmaceutical Preparations